Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
C. Fiandra(University of Turin), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Andrea Riccardo Filippi(University of Turin), Pierfrancesco Franco(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Angela Botticella(Azienda Ospedaliero Universitaria San Giovanni Battista), Riccardo Ragona, Valeria Casanova Borca, P. Catuzzo, Santi Tofani, Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 109
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646